U.S. Colorectal Cancer Market

U.S. Colorectal Cancer Market

 

RELEASE DATE
28-Dec-2009
REGION
North America
Research Code: N1EC-01-00-00-00
SKU: HC02047-NA-MR_07385
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC02047-NA-MR_07385

$4,950.00

$3,712.50save 25 %

DownloadLink
ENQUIRE NOW

Description

This research service provides the market overview, market trends, patient and revenue forecasts for colorectal cancer in the U.S. from 2006-2016. The patient population and revenue forecasts are discussed in terms of staging and line of therapy. This includes in-depth analysis of the market segmented by line of therapy providing competitive information and pipeline analysis. This research service also captures results from the Frost & Sullivan "Voice of the Customer" analysis of drug delivery in oncology. This research service serves as an update to F205-52 on the U.S. colorectal cancer market published in 2005-06.

Table of Contents

U.S. Colorectal Cancer Market

  • Introduction

Research Scope and Methodology

  • Scope and Segmentation
  • Research Methodology

Market Overview

  • Colorectal Cancer
  • Market Engineering Measurements
  • Staging Definitions
  • Treatment by Stage
  • Cost of Therapy Estimations
  • Product Analysis

Competitive Analysis

Patient Forecasts

  • Competitive Structure
  • Industry Challenges
  • Pipeline Analysis
  • Market Share Analysis

Revenue Forecasts

  • Incidence and Staging Forecasts
  • Patient Forecasts by Line of Therapy

Voice of the Customer Analysis

  • Total Market Forecasts
  • Adjuvant Therapy Forecasts
  • First-line Therapy Forecasts
  • Second and Third-line Therapy Forecasts
  • Combined Forecasts by Line of Therapy

Decision Support Databases

This research service provides the market overview, market trends, patient and revenue forecasts for colorectal cancer in the U.S. from 2006-2016. The patient population and revenue forecasts are discussed in terms of staging and line of therapy. This includes in-depth analysis of the market segmented by line of therapy providing competitive information and pipeline analysis. This research service also captures results from the Frost & Sullivan 'Voice of the Customer' analysis of drug delivery in oncology. This research service serves as an update to F205-52 on the U.S. colorectal cancer market published in 2005-06.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number N1EC-01-00-00-00
Is Prebook No